Cargando…

Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy

BACKGROUND: Autosomal dominant optic atrophy (ADOA, Kjer disease, MIM #165500) is the most common form of hereditary optic neuropathy. Mutations in OPA1 located at chromosome 3q28 are the predominant cause for ADOA explaining between 32 and 89% of cases. Although deletions of OPA1 were recently repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Almind, Gitte J, Grønskov, Karen, Milea, Dan, Larsen, Michael, Brøndum-Nielsen, Karen, Ek, Jakob
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079616/
https://www.ncbi.nlm.nih.gov/pubmed/21457585
http://dx.doi.org/10.1186/1471-2350-12-49
_version_ 1782202029136936960
author Almind, Gitte J
Grønskov, Karen
Milea, Dan
Larsen, Michael
Brøndum-Nielsen, Karen
Ek, Jakob
author_facet Almind, Gitte J
Grønskov, Karen
Milea, Dan
Larsen, Michael
Brøndum-Nielsen, Karen
Ek, Jakob
author_sort Almind, Gitte J
collection PubMed
description BACKGROUND: Autosomal dominant optic atrophy (ADOA, Kjer disease, MIM #165500) is the most common form of hereditary optic neuropathy. Mutations in OPA1 located at chromosome 3q28 are the predominant cause for ADOA explaining between 32 and 89% of cases. Although deletions of OPA1 were recently reported in ADOA, the frequency of OPA1 genomic rearrangements in Denmark, where ADOA has a high prevalence, is unknown. The aim of the study was to identify copy number variations in OPA1 in Danish ADOA patients. METHODS: Forty unrelated ADOA patients, selected from a group of 100 ADOA patients as being negative for OPA1 point mutations, were tested for genomic rearrangements in OPA1 by multiplex ligation probe amplification (MLPA). When only one probe was abnormal results were confirmed by additional manually added probes. Segregation analysis was performed in families with detected mutations when possible. RESULTS: Ten families had OPA1 deletions, including two with deletions of the entire coding region and eight with intragenic deletions. Segregation analysis was possible in five families, and showed that the deletions segregated with the disease. CONCLUSION: Deletions in the OPA1 gene were found in 10 patients presenting with phenotypic autosomal dominant optic neuropathy. Genetic testing for deletions in OPA1 should be offered for patients with clinically diagnosed ADOA and no OPA1 mutations detected by DNA sequencing analysis.
format Text
id pubmed-3079616
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30796162011-04-20 Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy Almind, Gitte J Grønskov, Karen Milea, Dan Larsen, Michael Brøndum-Nielsen, Karen Ek, Jakob BMC Med Genet Research Article BACKGROUND: Autosomal dominant optic atrophy (ADOA, Kjer disease, MIM #165500) is the most common form of hereditary optic neuropathy. Mutations in OPA1 located at chromosome 3q28 are the predominant cause for ADOA explaining between 32 and 89% of cases. Although deletions of OPA1 were recently reported in ADOA, the frequency of OPA1 genomic rearrangements in Denmark, where ADOA has a high prevalence, is unknown. The aim of the study was to identify copy number variations in OPA1 in Danish ADOA patients. METHODS: Forty unrelated ADOA patients, selected from a group of 100 ADOA patients as being negative for OPA1 point mutations, were tested for genomic rearrangements in OPA1 by multiplex ligation probe amplification (MLPA). When only one probe was abnormal results were confirmed by additional manually added probes. Segregation analysis was performed in families with detected mutations when possible. RESULTS: Ten families had OPA1 deletions, including two with deletions of the entire coding region and eight with intragenic deletions. Segregation analysis was possible in five families, and showed that the deletions segregated with the disease. CONCLUSION: Deletions in the OPA1 gene were found in 10 patients presenting with phenotypic autosomal dominant optic neuropathy. Genetic testing for deletions in OPA1 should be offered for patients with clinically diagnosed ADOA and no OPA1 mutations detected by DNA sequencing analysis. BioMed Central 2011-04-04 /pmc/articles/PMC3079616/ /pubmed/21457585 http://dx.doi.org/10.1186/1471-2350-12-49 Text en Copyright ©2011 Almind et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Almind, Gitte J
Grønskov, Karen
Milea, Dan
Larsen, Michael
Brøndum-Nielsen, Karen
Ek, Jakob
Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
title Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
title_full Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
title_fullStr Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
title_full_unstemmed Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
title_short Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
title_sort genomic deletions in opa1 in danish patients with autosomal dominant optic atrophy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079616/
https://www.ncbi.nlm.nih.gov/pubmed/21457585
http://dx.doi.org/10.1186/1471-2350-12-49
work_keys_str_mv AT almindgittej genomicdeletionsinopa1indanishpatientswithautosomaldominantopticatrophy
AT grønskovkaren genomicdeletionsinopa1indanishpatientswithautosomaldominantopticatrophy
AT mileadan genomicdeletionsinopa1indanishpatientswithautosomaldominantopticatrophy
AT larsenmichael genomicdeletionsinopa1indanishpatientswithautosomaldominantopticatrophy
AT brøndumnielsenkaren genomicdeletionsinopa1indanishpatientswithautosomaldominantopticatrophy
AT ekjakob genomicdeletionsinopa1indanishpatientswithautosomaldominantopticatrophy